APA

Demirkiran A., Sewgobind V. D. K. D., van der Weijde J., Kok A., Baan C. C., Kwekkeboom J., Tilanus H. W., Metselaar H. J. & van der Laan L. J. W. (20090514). Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. : Transplantation.

Chicago

Demirkiran Ahmet, Sewgobind Varsha D K D, van der Weijde Joyce, Kok Alice, Baan Carla C, Kwekkeboom Jaap, Tilanus Hugo W, Metselaar Herold J and van der Laan Luc J W. 20090514. Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. : Transplantation.

Harvard

Demirkiran A., Sewgobind V. D. K. D., van der Weijde J., Kok A., Baan C. C., Kwekkeboom J., Tilanus H. W., Metselaar H. J. and van der Laan L. J. W. (20090514). Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. : Transplantation.

MLA

Demirkiran Ahmet, Sewgobind Varsha D K D, van der Weijde Joyce, Kok Alice, Baan Carla C, Kwekkeboom Jaap, Tilanus Hugo W, Metselaar Herold J and van der Laan Luc J W. Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. : Transplantation. 20090514.